Delivery Order SPE2DB22D2206-SPE2DB23FJP69

The Defense Logistics Agency issued a $46,200.62 delivery order to Amerisourcebergen Drug Corp on March 20, 2026, for TIBSOVO 250 MG tablets (60-count supply), with an ultimate completion date of April 10, 2026. The order is issued under a parent Indefinite Delivery Contract with DLA Troop Support Medical valued at $999,999,999.00 through December 2026, which supports global pharmaceutical supply to military healthcare programs. Place of performance is Conshohocken, Pennsylvania. The order is...

The Defense Logistics Agency Troop Support Medical awarded a $19,482 delivery order to Amerisourcebergen Drug Corp Corporate Office Division for 250 mg tablets of TIBSOVO. Under the terms of the firm fixed price contract, Amerisourcebergen will deliver 60 tablets of the specified medication to a location in Conshohocken, Pennsylvania, with performance required between July 10-31, 2023. No additional details were provided regarding major subcontractors or a potential set-aside designation. The...

The Defense Logistics Agency awarded a $21,827.40 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 60 tablets of TIBSOVO 250 mg on August 7, 2025, with completion scheduled for August 28, 2025. This non-set-aside award is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The delivery order will be fulfilled from AmerisourceBergen's corporate office location in...

The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for 60 tablets of TIBSOVO 250 mg, a pharmaceutical product used in oncology treatment. This firm fixed-price delivery order, valued at $21,827.40, was competitively awarded without set-aside provisions and is scheduled for completion by May 14, 2025. The order was placed on April 23, 2025, and will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order...

The Defense Logistics Agency issued a $23,100.31 delivery order to Amerisourcebergen Drug Corp on March 18, 2026, for TIBSOVO 250 mg tablets (60-count). The order is issued under the DLA Troop Support Medical Indefinite Delivery Contract (IDC) valued at $999,999,999.00 through December 2026, a comprehensive global pharmaceutical support vehicle enabling supply of a broad range of pharmaceutical products and medical supplies to military healthcare programs worldwide. Place of performance is...

The Defense Logistics Agency awarded a $21,827.40 delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Tibsovo 250 mg tablets (60-count units). This is a firm fixed price, competitively awarded contract with no set-aside designation and a completion deadline of September 22, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement and is performing the work at its corporate...

The Defense Logistics Agency awarded a delivery order valued at $21,827.41 to AmerisourceBergen Drug Corp for TIBSOVO 250 mg tablets (60-count units) on November 6, 2025, with completion scheduled for December 1, 2025. This firm fixed-price contract represents a non-competitive delivery order issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999 global pharmaceutical support vehicle running through December 2026. The...

The Defense Logistics Agency (DLA) awarded a delivery order valued at $23,100.31 to AmerisourceBergen Drug Corp for the supply of TIBSOVO (ivosidenib) 250 mg tablets (60-count packages) on January 12, 2026, with an ultimate completion date of February 3, 2026. This is a firm fixed-price, non-set-aside contract with place of performance in Conshohocken, Pennsylvania. The award represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with...

AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order from the Defense Logistics Agency (DLA) on November 4, 2025, for TIBSOVO 250 mg tablets (60-count supply) with a firm fixed price ceiling value of $21,827.41. The contract is scheduled for completion by November 26, 2025. This is a competitively awarded, non-set-aside delivery order issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA...

The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $19,482.16 to Amerisourcebergen Drug Corporation to supply 60 tablets of the oncology medication TIBSOVO (gilteritinib) 250mg. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a period spanning June 22, 2023 through July 14, 2023. As a major provider of pharmaceuticals and medical supplies to the U.S. Department of Defense, this order for cancer treatment drugs aligns with...